Cooperative Planning Grant for Comprehensive Minority I*

描述(由申请人提供) 这是向国家癌症研究所提交的U56修订申请，以支持马里兰东岸大学(UMES--一家为少数族裔服务的机构)和马里兰大学格林鲍姆癌症中心(UMGCC)之间“综合少数族裔机构和癌症中心伙伴关系”的规划和发展。这一伙伴关系的总体使命是通过癌症研究和推广，解决马里兰州东岸地区和巴尔的摩市少数民族人口在癌症发病率和死亡率方面的差异。无论是在全国还是在马里兰州，非裔美国人的癌症发病率和死亡率都有所上升，而一些癌症的存活率则较低。 这一伙伴关系的长期目标如下： 1.在癌症研究和癌症差异研究方面，建立UMES和UMGCC稳定、长期、互利的合作关系。这种关系将更加强调与马里兰州、特别是巴尔的摩市和东海岸少数民族癌症发病率不成比例有关的问题和问题； 2.提高UMES和UMGCC旨在惠及马里兰州服务不足地区少数群体的研究活动的有效性和广度； 3.建立和稳定UMES的独立、有竞争力的癌症研究能力、癌症研究培训和职业发展计划；以及 4.评价伙伴关系干预活动，并评估伙伴关系在每个机构的总体效力。 UMES是一个1890年的土地授予机构，也是一个历史上的黑人机构(一个为少数族裔服务的机构--MSI)，位于马里兰州(下东岸)的安妮公主，是一个多元化的、主要是农村的社区，有大量的少数族裔人口。UMGCC是马里兰大学的多学科癌症中心，位于巴尔的摩市。UMGCC为巴尔的摩市和整个马里兰州提供服务，并拥有NCI提供的P20癌症中心规划拨款。该伙伴关系的首席研究员是Kelly Mack，Ph.D.，(UMES)和Claudia Baket，M.D.，M.P.H.(UMGCCI UM医学院)。

DESCRIPTION (provided by applicant) This is a revised U56 application to the National Cancer Institute to support the planning and development of a "Comprehensive Minority Institution and Cancer Center Partnership" between the University of Maryland Eastern Shore (UMES--a minority serving institution) and the University of Maryland Greenebaum Cancer Center (UMGCC). The overall mission of this Partnership is to address the disparities in cancer morbidity and mortality in Maryland's minority populations on the Eastern Shore region and in Baltimore City through cancer research and outreach. African Americans, both nationally and in Maryland, have increased cancer incidence and mortality and lower survival rates for a number of cancers. The long-term goals for this partnership are as follows: 1.Create a stable, long-term, and collaborative relationship of mutual benefit between UMES and UMGCC in cancer research and cancer disparities research. This relationship will increase the emphasis on problems and issues relevant to the disproportionate cancer rates in minorities in Maryland especially in Baltimore City and on the Eastern Shore; 2. Improve the effectiveness and breadth of UMES and UMGCC research activities designed to benefit the minority populations in Maryland's underserved areas; 3. Build and stabilize the independent, competitive cancer research capacity, cancer research training, and career development programs at UMES; and 4. Evaluate Partnership intervention activities and assess the overall effectiveness of the Partnership in each institution. UMES is an 1890 land grant institution and a Historically Black Institution (a Minority-Serving Institution --MSI) located in Princess Anne, Maryland (the lower Eastern Shore), a diverse and largely rural community with a large minority population. UMGCC is the multidisciplinary cancer center of the University of Maryland and is located in Baltimore City. UMGCC serves Baltimore City as well as the entire State of Maryland, and has a P20 cancer center planning grant from NCI. The Principal Investigators for the Partnership are Kelly Mack, Ph.D., (UMES) and Claudia Baquet, M.D., M.P.H., (UMGCCI UM School of Medicine).